Analyze Diet
International journal for parasitology. Drugs and drug resistance2017; 7(3); 407-415; doi: 10.1016/j.ijpddr.2017.10.007

Risk factor analysis of equine strongyle resistance to anthelmintics.

Abstract: Intestinal strongyles are the most problematic endoparasites of equids as a result of their wide distribution and the spread of resistant isolates throughout the world. While abundant literature can be found on the extent of anthelmintic resistance across continents, empirical knowledge about associated risk factors is missing. This study brought together results from anthelmintic efficacy testing and risk factor analysis to provide evidence-based guidelines in the field. It involved 688 horses from 39 French horse farms and riding schools to both estimate Faecal Egg Count Reduction (FECR) after anthelmintic treatment and to interview farm and riding school managers about their practices. Risk factors associated with reduced anthelmintic efficacy in equine strongyles were estimated across drugs using a marginal modelling approach. Results demonstrated ivermectin efficacy (96.3% ± 14.5% FECR), the inefficacy of fenbendazole (42.8% ± 33.4% FECR) and an intermediate profile for pyrantel (90.3% ± 19.6% FECR). Risk factor analysis provided support to advocate for FEC-based treatment regimens combined with individual anthelmintic dosage and the enforcement of tighter biosecurity around horse introduction. The combination of these measures resulted in a decreased risk of drug resistance (relative risk of 0.57, p = 0.02). Premises falling under this typology also relied more on their veterinarians suggesting practitionners play an important role in the sustainability of anthelmintic usage. Similarly, drug resistance risk was halved in premises with frequent pasture rotation and with stocking rate below five horses/ha (relative risk of 0.53, p < 0.01). This is the first empirical risk factor analysis for anthelmintic resistance in equids. Our findings should guide the implementation of more sustained strongyle management in the field.
Publication Date: 2017-11-02 PubMed ID: 29149701PubMed Central: PMC5727347DOI: 10.1016/j.ijpddr.2017.10.007Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the factors contributing to the resistance of horse intestinal parasites, or strongyles, to deworming drugs. By studying 688 horses across 39 French horse farms and riding schools, the researchers were able to identify key practices that can help delay drug resistance, such as individual drug dosage, stricter biosecurity, frequent pasture rotation, and a lower number of horses per hectare.

Study Overview

  • The paper analyzes the risk factors associated with equine strongyles developing resistance to anthelmintic drugs, common treatments for parasitic worm infections in horses.
  • The study was conducted on 39 French horse farms and riding schools involving 688 horses. The aim was to estimate the Faecal Egg Count Reduction (FECR) after anthelmintic treatment and to understand the practices of farm and riding school managers.

Drugs Efficacy

  • Three anthelmintic drugs were tested for efficacy: ivermectin, fenbendazole, and pyrantel.
  • Results showed ivermectin to be the most effective with a reduction of 96.3% in faecal egg count. Pyrantel was intermediate with a 90.3% reduction, whereas fenbendazole was shown to be largely ineffective, with a 42.8% reduction.

Risk Factor Analysis

  • An analysis of risk factors was conducted to identify the practices associated with reduced anthelmintic efficacy.
  • Evidence-based guidelines were established from this study to ensure sustainable use of anthelmintics and slow down the spread of drug-resistant strongyles.
  • Factors reducing drug resistance risk included FEC-based treatment regimens, individual drug dosage, stricter biosecurity measures, frequent pasture rotation, and maintaining a stocking rate below five horses per hectare.
  • The study highlighted veterinarians’ crucial role in implementing these measures effectively, as it was observed that farms following these practices relied more heavily on their veterinarians.

Implications and Findings

  • This study is significant as it’s the first empirical risk factor analysis for anthelmintic resistance in horses, providing actionable insights to manage strongyles in the field more sustainably.
  • The recommended practices from this study can help reduce the risk of drug resistance, contributing to the longevity of anthelmintic drug efficacy and overall equine health.

Cite This Article

APA
Sallé G, Cortet J, Bois I, Dubès C, Guyot-Sionest Q, Larrieu C, Landrin V, Majorel G, Wittreck S, Woringer E, Couroucé A, Guillot J, Jacquiet P, Guégnard F, Blanchard A, Leblond A. (2017). Risk factor analysis of equine strongyle resistance to anthelmintics. Int J Parasitol Drugs Drug Resist, 7(3), 407-415. https://doi.org/10.1016/j.ijpddr.2017.10.007

Publication

ISSN: 2211-3207
NlmUniqueID: 101576715
Country: Netherlands
Language: English
Volume: 7
Issue: 3
Pages: 407-415

Researcher Affiliations

Sallé, G
  • INRA/Université de Tours UMR1282 Infectiologie et Santé Publique, France. Electronic address: Guillaume.Salle@inra.fr.
Cortet, J
  • INRA/Université de Tours UMR1282 Infectiologie et Santé Publique, France.
Bois, I
  • UMR INRA/ENV Toulouse 1225 IHAP, Ecole Nationale Vétérinaire de Toulouse, France.
Dubès, C
  • UMR INRA/ENV Toulouse 1225 IHAP, Ecole Nationale Vétérinaire de Toulouse, France.
Guyot-Sionest, Q
  • LUNAM University, Oniris, Unité de Recherche NP3, 102 Route de Gachet, 44300 Nantes, France.
Larrieu, C
  • LUNAM University, Oniris, Unité de Recherche NP3, 102 Route de Gachet, 44300 Nantes, France.
Landrin, V
  • Parasitology Dept, Dynamyc EnvA, UPEC, Ecole Nationale Vétérinaire D'Alfort, UPE, Maisons-Alfort, France.
Majorel, G
  • EPIA, INRA, VetAgroSup, University of Lyon, 69280 Marcy L'Etoile, France.
Wittreck, S
  • Merial SAS, 29 Avenue Tony Garnier, 69007 Lyon, France.
Woringer, E
  • Zoetis, 10 Rue Raymond David, 92240 Malakoff, France.
Couroucé, A
  • LUNAM University, Oniris, Unité de Recherche NP3, 102 Route de Gachet, 44300 Nantes, France.
Guillot, J
  • Parasitology Dept, Dynamyc EnvA, UPEC, Ecole Nationale Vétérinaire D'Alfort, UPE, Maisons-Alfort, France.
Jacquiet, P
  • UMR INRA/ENV Toulouse 1225 IHAP, Ecole Nationale Vétérinaire de Toulouse, France.
Guégnard, F
  • INRA/Université de Tours UMR1282 Infectiologie et Santé Publique, France.
Blanchard, A
  • INRA/Université de Tours UMR1282 Infectiologie et Santé Publique, France.
Leblond, A
  • EPIA, INRA, VetAgroSup, University of Lyon, 69280 Marcy L'Etoile, France.

MeSH Terms

  • Animals
  • Anthelmintics / pharmacology
  • Data Interpretation, Statistical
  • Drug Resistance
  • Feces / parasitology
  • Fenbendazole / pharmacology
  • Horses
  • Ivermectin / pharmacology
  • Parasite Egg Count / veterinary
  • Risk Factors
  • Strongyle Infections, Equine / drug therapy
  • Strongyle Infections, Equine / parasitology
  • Strongyloidea / drug effects

References

This article includes 57 references
  1. Anonymous . In: Code de la Santé Publique - Article R5141-112. Française R., editor. 2007.
  2. Anonymous, 2016. http://www.ircp.anmv.anses.fr/rcp.aspx?NomMedicament=EQUEST+PRAMOX, last access October 2017. Agence Nationale du Médicament Vétérinaire.
  3. Avramenko RW, Redman EM, Lewis R, Yazwinski TA, Wasmuth JD, Gilleard JS. Exploring the gastrointestinal “nemabiome”: deep amplicon sequencing to quantify the species composition of parasitic nematode communities.. PLoS One 2015;10:e0143559.
    pmc: PMC4668017pubmed: 26630572
  4. Boersema JH, Eysker M, Maas J, vanderAar WM. Comparison of the reappearance of strongyle eggs in foals, yearlings, and adult horses after treatment with ivermectin or pyrantel.. Vet. Quart. 1996;18:7–9.
    pubmed: 8833604
  5. Boersema JH, Eysker M, van der Aar WM. The reappearance of strongyle eggs in the faeces of horses after treatment with moxidectin.. Vet. Q. 1998;20:15–17.
    pubmed: 9477529
  6. Canever RJ, Braga PR, Boeckh A, Grycajuck M, Bier D, Molento MB. Lack of Cyathostomin sp. reduction after anthelmintic treatment in horses in Brazil.. Vet. Parasitol. 2013;194:35–39.
    pubmed: 23318166
  7. Chernick MR. Bootstrap Methods: a Practitioner's Guide.. 1999.
  8. Coles GC, Bauer C, Borgsteede FH, Geerts S, Klei TR, Taylor MA, Waller PJ. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) methods for the detection of anthelmintic resistance in nematodes of veterinary importance.. Vet. Parasitol. 1992;44:35–44.
    pubmed: 1441190
  9. Corbett CJ, Love S, Moore A, Burden FA, Matthews JB, Denwood MJ. The effectiveness of faecal removal methods of pasture management to control the cyathostomin burden of donkeys.. Parasit. Vectors. 2014;7:48.
    pmc: PMC3904009pubmed: 24460700
  10. Corning S. Equine cyathostomins: a review of biology, clinical significance and therapy.. Parasit. Vectors. 2009;2(Suppl. 2):S1.
    pmc: PMC2751837pubmed: 19778462
  11. Crellen T, Walker M, Lamberton PH, Kabatereine NB, Tukahebwa EM, Cotton JA, Webster JP. Reduced efficacy of praziquantel against schistosoma mansoni is associated with multiple rounds of mass drug administration.. Clin. Infect. Dis. 2016;63:1151–1159.
    pmc: PMC5064161pubmed: 27470241
  12. Daniels SP, Proudman CJ. Shortened egg reappearance after ivermectin or moxidectin use in horses in the UK.. Vet. J. 2016;218:36–39.
    pubmed: 27938707
  13. Dash KM, Hall E, Barger IA. The role of arithmetic and geometric mean worm egg counts in faecal egg count reduction tests and in monitoring strategic drenching programs in sheep.. Aust. Vet. J. 1988;65:66–68.
    pubmed: 3355458
  14. Easton S, Pinchbeck GL, Tzelos T, Bartley DJ, Hotchkiss E, Hodgkinson JE, Matthews JB. Investigating interactions between UK horse owners and prescribers of anthelmintics.. Prev. Vet. Med. 2016;135:17–27.
    pubmed: 27931925
  15. Fritzen B, Rohn K, Schnieder T, von Samson-Himmelstjerna G. Endoparasite control management on horse farms–lessons from worm prevalence and questionnaire data.. Equine Vet. J. 2010;42:79–83.
    pubmed: 20121919
  16. Geurden T, van Doorn D, Claerebout E, Kooyman F, De Keersmaecker S, Vercruysse J, Besognet B, Vanimisetti B, di Regalbono AF, Beraldo P, Di Cesare A, Traversa D. Decreased strongyle egg re-appearance period after treatment with ivermectin and moxidectin in horses in Belgium, Italy and The Netherlands.. Vet. Parasitol. 2014;204:291–296.
    pubmed: 24880643
  17. Giles CJ, Urquhart KA, Longstaffe JA. Larval cyathostomiasis (immature trichonema-induced enteropathy): a report of 15 clinical cases.. Equine Vet. J. 1985;17:196–201.
    pubmed: 4076127
  18. Harrell FE, Dupont C. Hmisc: Harrell Miscellaneous.. 2017.
  19. Hinney B, Wirtherle NC, Kyule M, Miethe N, Zessin KH, Clausen PH. Prevalence of helminths in horses in the state of Brandenburg, Germany.. Parasitol. Res. 2011;108:1083–1091.
    pubmed: 21472400
  20. Hinney B, Wirtherle NC, Kyule M, Miethe N, Zessin KH, Clausen PH. A questionnaire survey on helminth control on horse farms in Brandenburg, Germany and the assessment of risks caused by different kinds of management.. Parasitol. Res. 2011;109:1625–1635.
    pubmed: 21559764
  21. Højsgaard S, H, U, Yan J. The R package geepack for generalized estimating equations.. J. Stat. Softw. 2006;15:1–11.
  22. Humphry RW, Cameron A, Gunn GJ. A practical approach to calculate sample size for herd prevalence surveys.. Prev. Vet. Med. 2004;65:173–188.
    pubmed: 15488269
  23. Kaplan RM, Vidyashankar AN. An inconvenient truth: global worming and anthelmintic resistance.. Veterinary Parasitol. 2012;186:70–78.
    pubmed: 22154968
  24. Kennedy DA, Read AF. Why does drug resistance readily evolve but vaccine resistance does not?. Proc. Biol. Sci. 2017;284.
    pmc: PMC5378080pubmed: 28356449
  25. Kenyon F, Greer AW, Coles GC, Cringoli G, Papadopoulos E, Cabaret J, Berrag B, Varady M, Van Wyk JA, Thomas E, Vercruysse J, Jackson F. The role of targeted selective treatments in the development of refugia-based approaches to the control of gastrointestinal nematodes of small ruminants.. Vet. Parasitol. 2009;164:3–11.
    pubmed: 19450930
  26. Lake SL, Matthews JB, Kaplan RM, Hodgkinson JE. Determination of genomic DNA sequences for beta-tubulin isotype 1 from multiple species of cyathostomin and detection of resistance alleles in third-stage larvae from horses with naturally acquired infections.. Parasites Vectors. 2009;2.
    pmc: PMC2751842pubmed: 19778467
  27. Lê S, Josse J, Husson F. FactoMineR: a package for multivariate analysis.. J. Stat. Softw. 2008;25:1–18.
  28. Lendal S, Larsen MM, Bjorn H, Craven J, Chriel M, Olsen SN. A questionnaire survey on nematode control practices on horse farms in Denmark and the existence of risk factors for the development of anthelmintic resistance.. Vet. Parasitol. 1998;78:49–63.
    pubmed: 9703619
  29. Lichtenfels JR, Kharchenko VA, Dvojnos GM. Illustrated identification keys to strongylid parasites (Strongylidae: Nematoda) of horses, zebras and asses (Equidae). Vet. Parasitol. 2008;156:4–161.
    pubmed: 18603375
  30. Lind EO, Rautalinko E, Uggla A, Waller PJ, Morrison DA, Hoglund J. Parasite control practices on Swedish horse farms.. Acta Vet. Scand. 2007;49:25.
    pmc: PMC2093939pubmed: 17897438
  31. Love S, Murphy D, Mellor D. Pathogenicity of cyathostome infection.. Vet. Parasitol. 1999;85:113–121. discussion 121-112, 215–125.
    pubmed: 10485358
  32. Lyons ET, Tolliver SC, Collins SS, Ionita M, Kuzmina TA, Rossano M. Field tests demonstrating reduced activity of ivermectin and moxidectin against small strongyles in horses on 14 farms in Central Kentucky in 2007-2009.. Parasitol. Res. 2011;108:355–360.
    pubmed: 20862493
  33. Lyons ET, Tolliver SC, Ionita M, Collins SS. Evaluation of parasiticidal activity of fenbendazole, ivermectin, oxibendazole, and pyrantel pamoate in horse foals with emphasis on ascarids (Parascaris equorum) in field studies on five farms in Central Kentucky in 2007.. Parasitol. Res. 2008;103:287–291.
    pubmed: 18470536
  34. Maddox TW, Pinchbeck GL, Clegg PD, Wedley AL, Dawson S, Williams NJ. Cross-sectional study of antimicrobial-resistant bacteria in horses. Part 2: risk factors for faecal carriage of antimicrobial-resistant Escherichia coli in horses.. Equine Vet. J. 2012;44:297–303.
    pubmed: 21848536
  35. Matthews JB. Anthelmintic resistance in equine nematodes.. Int. J. Parasitol. Drugs Drug Resist. 2014;4:310–315.
    pmc: PMC4266799pubmed: 25516842
  36. Michel JF. Epidemiology and control of gastrointestinal helminths in domestic animals.. In: Bossche HV, Thienpont D, Janssens PG, editors. Chemotherapy of Gastrointestinal Helminths. Springer Berlin Heidelberg; Berlin, Heidelberg: 1985. pp. 67–123.
  37. Molento MB, Antunes J, Bentes RN, Coles GC. Anthelmintic resistant nematodes in Brazilian horses.. Vet. Rec. 2008;162:384–385.
    pubmed: 18359933
  38. Murphy D, Love S. The pathogenic effects of experimental cyathostome infections in ponies.. Vet. Parasitol. 1997;70:99–110.
    pubmed: 9195714
  39. Nielsen MK. Sustainable equine parasite control: perspectives and research needs.. Vet. Parasitol. 2012;185:32–44.
    pubmed: 22055611
  40. Nielsen MK, Jacobsen S, Olsen SN, Bousquet E, Pihl T. Nonstrangulating intestinal infarction associated with Strongylus vulgaris in referred Danish equine cases.. Equine Vet. J. 2016;48:376–379.
    pubmed: 25604521
  41. Nielsen MK, Vidyashankar AN, Olsen SN, Monrad J, Thamsborg SM. Strongylus vulgaris associated with usage of selective therapy on Danish horse farms-is it reemerging?. Vet. Parasitol. 2012;189:260–266.
    pubmed: 22703964
  42. O'Meara B, Mulcahy G. A survey of helminth control practices in equine establishments in Ireland.. Vet. Parasitol. 2002;109:101–110.
    pubmed: 12383629
  43. Peregrine AS, Molento MB, Kaplan RM, Nielsen MK. Anthelmintic resistance in important parasites of horses: does it really matter?. Vet. Parasitol. 2014;201:1–8.
    pubmed: 24485565
  44. R Core Team. R: a Language and Environment for Statistical Computing.. R Foundation for Statistical Computing; Vienna: 2016.
  45. Relf VE, Lester HE, Morgan ER, Hodgkinson JE, Matthews JB. Anthelmintic efficacy on UK Thoroughbred stud farms.. Int. J. Parasitol. 2014;44:507–514.
    pubmed: 24746779
  46. Relf VE, Morgan ER, Hodgkinson JE, Matthews JB. A questionnaire study on parasite control practices on UK breeding Thoroughbred studs.. Equine Vet. J. 2012;44:466–471.
    pubmed: 22050130
  47. Sallé G, Cabaret J. Meta-analysis of cyathostomins community structure and diversity; p. 220.. International Conference of the World Association for the Advancement of Veterinary Parasitology. The United-Kingdom; Liverpool: 2015.
  48. Silvestre A, Cabaret J, Humbert JF. Effect of benzimidazole under-dosing on the resistant allele frequency in Teladorsagia circumcincta (Nematoda). Parasitology 2001;123:103–111.
    pubmed: 11467778
  49. Slocombe JO, de Gannes RV. Cyathostomes in horses in Canada resistant to pyrantel salts and effectively removed by moxidectin.. Vet. Parasitol. 2006;140:181–184.
    pubmed: 16682123
  50. Smith G, Grenfell BT, Isham V, Cornell S. Anthelmintic resistance revisited: under-dosing, chemoprophylactic strategies, and mating probabilities.. Int. J. Parasitol. 1999;29:77–91. discussion 93–74.
    pubmed: 10048821
  51. Traversa D, Castagna G, von Samson-Himmelstjerna G, Meloni S, Bartolini R, Geurden T, Pearce MC, Woringer E, Besognet B, Milillo P, D'Espois M. Efficacy of major anthelmintics against horse cyathostomins in France.. Vet. Parasitol. 2012;188:294–300.
    pubmed: 22538094
  52. Traversa D, Klei TR, Iorio R, Paoletti BP, Lia RP, Otranto D, Sparagano OA, Giangaspero A. Occurrence of anthelmintic resistant equine cyathostome populations in central and southern Italy.. Prev. Vet. Med. 2007;82:314–320.
    pubmed: 17719664
  53. Traversa D, von Samson-Himmelstjerna G, Demeler J, Milillo P, Schurmann S, Barnes H, Otranto D, Perrucci S, di Regalbono AF, Beraldo P, Boeckh A, Cobb R. Anthelmintic resistance in cyathostomin populations from horse yards in Italy, United Kingdom and Germany.. Parasit. Vectors. 2009;2(Suppl. 2):S2.
    pmc: PMC2751838pubmed: 19778463
  54. Tzelos T, Barbeito JS, Nielsen MK, Morgan ER, Hodgkinson JE, Matthews JB. Strongyle egg reappearance period after moxidectin treatment and its relationship with management factors in UK equine populations.. Vet. Parasitol. 2017;237:70–76.
    pubmed: 28249767
  55. von Samson-Himmelstjerna G, Fritzen B, Demeler J, Schurmann S, Rohn K, Schnieder T, Epe C. Cases of reduced cyathostomin egg-reappearance period and failure of Parascaris equorum egg count reduction following ivermectin treatment as well as survey on pyrantel efficacy on German horse farms.. Vet. Parasitol. 2007;144:74–80.
    pubmed: 17112667
  56. Walker M, Churcher TS, Basanez MG. Models for measuring anthelmintic drug efficacy for parasitologists.. Trends Parasitol. 2014;30:528–537.
    pubmed: 25217844
  57. Zuur AF, Ieno EN, Elphick CS. A protocol for data exploration to avoid common statistical problems.. Methods Ecol. Evol. 2010;1:3–14.

Citations

This article has been cited 14 times.
  1. Abbas G, Nielsen MK, E-Hage C, Ghafar A, Beveridge I, Bauquier J, Beasley A, Wilkes EJA, Carrigan P, Cudmore L, Jacobson C, Hughes KJ, Jabbar A. Recent advances in intestinal helminth parasites of horses in the Asia-Pacific region: Current trends, challenges and future directions. Int J Parasitol Drugs Drug Resist 2025 Dec;29:100622.
    doi: 10.1016/j.ijpddr.2025.100622pubmed: 41135277google scholar: lookup
  2. Cabaret J. Independent Development of Resistance to Main Classes of Anthelmintics by Gastrointestinal Nematodes of Ruminants and Horses. Pathogens 2025 Sep 5;14(9).
    doi: 10.3390/pathogens14090898pubmed: 41011797google scholar: lookup
  3. Hedberg Alm Y, Tydén E, Martin F, Lernå J, Halvarsson P. Farm size and biosecurity measures associated with Strongylus vulgaris infection in horses. Equine Vet J 2025 May;57(3):703-711.
    doi: 10.1111/evj.14212pubmed: 39171858google scholar: lookup
  4. Chaucheyras-Durand F, Sacy A, Karges K, Apper E. Gastro-Intestinal Microbiota in Equines and Its Role in Health and Disease: The Black Box Opens. Microorganisms 2022 Dec 19;10(12).
  5. Amer MM, Desouky AY, Helmy NM, Abdou AM, Sorour SS. Identifying 3(rd) larval stages of common strongylid and non-strongylid nematodes (class: Nematoda) infecting Egyptian equines based on morphometric analysis. BMC Vet Res 2022 Dec 12;18(1):432.
    doi: 10.1186/s12917-022-03526-8pubmed: 36503529google scholar: lookup
  6. Nielsen MK. Anthelmintic resistance in equine nematodes: Current status and emerging trends. Int J Parasitol Drugs Drug Resist 2022 Dec;20:76-88.
    doi: 10.1016/j.ijpddr.2022.10.005pubmed: 36342004google scholar: lookup
  7. Malsa J, Courtot É, Boisseau M, Dumont B, Gombault P, Kuzmina TA, Basiaga M, Lluch J, Annonay G, Dhorne-Pollet S, Mach N, Sutra JF, Wimel L, Dubois C, Guégnard F, Serreau D, Lespine A, Sallé G, Fleurance G. Effect of sainfoin (Onobrychis viciifolia) on cyathostomin eggs excretion, larval development, larval community structure and efficacy of ivermectin treatment in horses. Parasitology 2022 Sep;149(11):1439-1449.
    doi: 10.1017/S0031182022000853pubmed: 35929352google scholar: lookup
  8. Dyary HO, Banaz HQ. First Report of Multiple Drug-resistant Gastrointestinal Nematodes of Sheep in Arbat District, Sulaymaniyah, Iraq Detected By in Vivo and in Vitro Methods. J Vet Res 2021 Sep;65(3):293-299.
    doi: 10.2478/jvetres-2021-0047pubmed: 34917841google scholar: lookup
  9. Sallé G, Canlet C, Cortet J, Koch C, Malsa J, Reigner F, Riou M, Perrot N, Blanchard A, Mach N. Integrative biology defines novel biomarkers of resistance to strongylid infection in horses. Sci Rep 2021 Jul 12;11(1):14278.
    doi: 10.1038/s41598-021-93468-2pubmed: 34253752google scholar: lookup
  10. Studzińska MB, Sallé G, Roczeń-Karczmarz M, Szczepaniak K, Demkowska-Kutrzepa M, Tomczuk K. A survey of ivermectin resistance in Parascaris species infected foals in south-eastern Poland. Acta Vet Scand 2020 Jun 5;62(1):28.
    doi: 10.1186/s13028-020-00526-2pubmed: 32503589google scholar: lookup
  11. Forteau L, Dumont B, Sallé G, Bigot G, Fleurance G. Horses grazing with cattle have reduced strongyle egg count due to the dilution effect and increased reliance on macrocyclic lactones in mixed farms. Animal 2020 May;14(5):1076-1082.
    doi: 10.1017/S1751731119002738pubmed: 31679547google scholar: lookup
  12. de Lagarde M, Larrieu C, Praud K, Schouler C, Doublet B, Sallé G, Fairbrother JM, Arsenault J. Prevalence, risk factors, and characterization of multidrug resistant and extended spectrum β-lactamase/AmpC β-lactamase producing Escherichia coli in healthy horses in France in 2015. J Vet Intern Med 2019 Mar;33(2):902-911.
    doi: 10.1111/jvim.15415pubmed: 30648296google scholar: lookup
  13. Mougin C, Artige E, Marchand F, Mondy S, Ratié C, Sellier N, Castagnone-Sereno P, D'Acier AC, Esmenjaud D, Faivre-Primot C, Granjon L, Hamelet V, Lange F, Pagès S, Rimet F, Ris N, Sallé G. BRC4Env, a network of Biological Resource Centres for research in environmental and agricultural sciences. Environ Sci Pollut Res Int 2018 Dec;25(34):33849-33857.
    doi: 10.1007/s11356-018-1973-7pubmed: 29675816google scholar: lookup
  14. Clark A, Sallé G, Ballan V, Reigner F, Meynadier A, Cortet J, Koch C, Riou M, Blanchard A, Mach N. Strongyle Infection and Gut Microbiota: Profiling of Resistant and Susceptible Horses Over a Grazing Season. Front Physiol 2018;9:272.
    doi: 10.3389/fphys.2018.00272pubmed: 29618989google scholar: lookup